AXTLE
Active substance: pemetrexed
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · PEMETREXED 100 mg/4mL
United StatesActive
Marketing holder: Avyxa Pharma, LLC
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 3
- PEMETREXED · 100 mg/4mL
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 46 |
|
| EU 5 |
|
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-33bb-79df-8646-a6e93447c0e6,01a120c3-34e5-7d0c-a32f-648f24f7c8b7,01a120c3-35aa-7aaf-be37-edaf5c2ec9c2,01a120c3-3ba1-7eb7-b0a8-5efb71fb0fec,01a120c3-438b-7331-bccb-03e190e8eecf;count=37 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-3be7-744c-b182-81807e99a722,01a1208d-bb7b-7658-a3ba-bbed83374005,01a1208d-dac9-7aa4-b2d8-3438d46b2234,01a12092-a231-7bf3-954e-9a662629fa43,01a12093-03af-7d35-831e-2cd7e2906495;count=9 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- 83831-131
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
- product · openFDA NDC · 83831-131 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 83831-131 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 83831-131 · Verified 2026-10-09 · open in source